Earnings3386COSMO BIO COMPANY,LIMITED
Cosmo BIO Company Ltd. Reports Q2 Revenue of 5.9 billion, Up 10%
TOKYO, Aug 05 (Pulse News Wire) – Cosmo Bio Company, Ltd. (3386.T) reported consolidated results for Q2 FY2026 (ending December 2026).
Revenue was ¥5.9 billion (+9.5% YoY). operating profit was ¥279 million (+1.2%). net profit attributable to shareholders was ¥277 million (+10.5%).
Total assets stood at ¥12.8 billion with an equity ratio of 76.0%. The company declared an annual dividend of ¥25 per share. The full-year forecast for the current fiscal year is revenue of ¥11.5 billion (+6.8%).
Financial results — FY2026/12 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥5,914M | +9.5% |
| Operating profit | ¥279M | +1.2% |
| Net profit | ¥277M | +10.5% |
Next period forecast
Revenue
¥11,500M
+6.8%Op. profit
¥270M
-21.3%Net profit
¥320M
-5.1%Figures in millions of yen
End of article